Misstated Text

In the Editorial entitled “Sublingual Immunotherapy for Allergic Rhinitis: Is 2-Year Treatment Sufficient for Long-term Benefit?” published in the February 14, 2017, issue, there was an error in the text. In the first paragraph, the third sentence should have read, “The proportion of patients treated with AIT who do not maintain sustained allergen-specific tolerance varies from 0% to 55%, depending on factors including type of allergen, treatment duration, and the definition of relapse.” This article was corrected online.

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2lrrC0l
via IFTTT